Conn, P. Jeffrey
Lindsley, Craig W.
Meiler, Jens
Niswender, Colleen M.
Article History
First Online: 1 September 2014
Competing interests
: P.J.C., C.W.L. and C.M.N. receive research support from Bristol-Myers Squibb and AstraZeneca. Each of these three authors is an inventor on patents that protect different classes of metabotropic glutamate and muscarinic receptor allosteric modulators and have been licensed by Vanderbilt University to AstraZeneca, Bristol-Myers Squibb, and Johnson & Johnson. C.W.L. has consulted for AbbVie and received compensation. Over the past 2 years, P.J.C. has consulted for and received compensation from Pfizer, Cambridge, Massachusetts, USA.